Penn Medicine experts will be speaking and presenting data on the latest advances in cancer research and treatment at the American Association for Cancer Research’s 2014 Annual Meeting from April 5th through April 9th in San Diego. The program covers every aspect of cancer – from molecular biology, translational and clinical studies, epidemiology, and prevention to survivorship and patient advocacy.
Experts from Penn's Abramson Cancer Center are available to comment on a wide range of cancer research topics. To arrange interviews, please contact Steve Graff at email@example.com or 215-301-5221. Follow us on Twitter at @PennMedNews.
Watch this space for a news release as embargoes lift during the meeting.
Penn Medicine Physician to Co-Lead Stand Up to Cancer "Dream Team" to Fight Pancreatic Cancer
Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research at the Abramson Cancer Center, will be delivering a plenary talk titled “Engineering T cells for cancer: CARs in the clinic” on Monday, April 7 at 8:15 am PST. An expert in gene therapy and immunotherapeutic approaches to cancer treatment, Dr. June leads the team that published research showing sustained remissions among both adult and pediatric patients with advanced leukemias who were treated with genetically engineered versions of their own T cells. His team is developing strategies to expand this personalized approach into ovarian and pancreatic cancers and mesothelioma.
Peter C. Nowell, MD, the Gaylord P. and Mary Louise Harnwell professor emeritus in the Department of Pathology and Laboratory Medicine, will be formally inducted into the 2014 class of elected fellows of the AACR Academy on Friday, April 4.
M. Celeste Simon, PhD, a professor in the Department of Cell and Development Biology and scientific director and investigator at the Abramson Family Cancer Research Institute, has been elected to the AACR Board of Directors, and will assume her role at the start of the meeting on April 5.
Abramson Cancer Center
Perelman School of Medicine
University of Pennsylvania Health System
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.